Beijing Wehand-Viamin Biotech

Beijing Wehand-Viamin Biotech is a specialized pharmaceutical company based in Beijing, China, dedicated to the development and commercialization of active Vitamin D analogs. The company has established a leading position in the Chinese market for bone metabolism and calcium regulation therapies, focusing on indications such as osteoporosis, secondary hyperparathyroidism, and chronic kidney disease. Its product portfolio features high-barrier synthetic drugs, including eldecalcitol, alfacalcidol, and calcitriol. Wehand-Viamin integrates research, development, and GMP-certified manufacturing to ensure the quality of its complex steroidal compounds. By leveraging its expertise in Vitamin D receptor (VDR) signaling, the company continues to expand its pipeline into dermatological applications like psoriasis.